Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Conatus Pharmaceuticals Inc.

NASDAQ: CNATHealthcare / Biotechnology / USA
2.04+0.0100+0.49%Vol 513 4851Y Perf -60.62%
Feb 15th, 2019 16:00
BID2.09 ASK2.10
Open2.05 Previous Close2.03
Pre-Market2.10 After-Trading2.09
 0.07 3.45%  0.05 2.45%
Target Price
12.00 
Analyst Rating
Strong Buy 1.40
Potencial %
488.24 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
     36.96
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★+     39.37
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)62 
Earnings Rating
Buy
Price Range Ratio 52wk %
13.09 
Earnings Date
6th Mar 2019

Today's Price Range

2.002.07

 

52wk Range

1.157.95

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Month
9.09%
3 Months
-57.68%
6 Months
-48.35%
1 Year
-60.62%
3 Years
17.92%
5 Years
-82.17%

Quotes

Name / TickerPriceChg.Chg.%
CNAT2.040.01000.49
AAPL170.42-0.3800-0.22
GOOG1 113.65-8.0200-0.72
MSFT108.221.32001.23
XOM77.711.44001.89
WFC49.220.70001.44
JNJ136.382.07001.54
FB162.50-1.4500-0.88
GE10.090.05000.50
JPM105.553.13003.06
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
2.30
Current Ratio
2.40
Long Term Debt to Total Capital
0.45
Total Debt to Equity
0.83
Interest Coverage
-23.60
Leverage Ratio 3.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-50.60
EBITDA Margin
-50.30
Pre-tax Profit Margin
-
Profit Margin
-53.88
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
3.93
PS Ratios
2.49
Price to Cash Flow
6.70
Price to Free Cash Flow
-2.50
Cash Flow Per Share
-1.20
Price to Tangible Book
3.93
Book Value per Share
0.50
Enterprise Value (in ths.)
29 392
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-81.25
ROE last 12 Months
-77.08
Return on Assets (5Y Avg)
-28.11
ROA last 12 Months
-25.05
Return on Capital (5Y Avg)
-62.91
ROC last 12 Months
-50.10
Return on invested Capital Q
-14.58
Return on invested Capital Y
-46.32
Assets Turnover
0.10
Receivables Turnover
3.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
26 177
Revenue per Share
0.79
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.15-0.150.00
Q02 2018-0.20-0.1525.00
Q01 2018-0.17-0.170.00
Q04 2017-0.17-0.1511.76
Q03 2017-0.05-0.13-160.00
Q02 2017-0.11-0.19-72.73
Q01 2017-0.14-0.140.00
Q04 2016-0.32-0.35-9.38
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.140.00-
12/2018 FY-0.61-1.67Negative
3/2019 QR-0.130.00-
12/2019 FY-0.16-433.33Negative
Next Report Date6th Mar 2019
Estimated EPS Next Report-0.14
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume513 485
Shares Outstanding (in ths.)30 262
Trades Count1 541
Dollar Volume1 003 649
Avg. Volume570 751
Avg. Weekly Volume444 585
Avg. Monthly Volume603 251
Avg. Quarterly Volume820 459

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

35%65%

Bearish Bullish

56%44%

Bearish Bullish

60%40%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
4 (80.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (20.00 %)
1 (20.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.40
Strong Buy
1.40
Strong Buy
1.00

There are no comments yet.

News